Reliv' International, Inc. develops, manufactures, and markets nutritional supplements that address basic nutrition, wellness needs, weight management, and sports nutrition. It offers 20 nutritional supplements, primarily, including Reliv Classic and Reliv NOW, which are basic nutritional supplements containing a balanced blend of vitamins, minerals, proteins, and herbs; Innergize!, an isotonic sports supplement in two flavors; FibRestore, a fiber and antioxidant supplement; and LunaRich X, a soy concentrate with elevated levels of lunasin in capsule form. The company markets and sells its products through a network of independent distributors in the United States, Australia, Austria, Canada, France, Germany, Indonesia, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, Singapore, and the United Kingdom. Reliv' International, Inc. was founded in 1984 and is headquartered in Chesterfield, Missouri.
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorConsumer Staples
SymbolNASDAQ:RELV
CUSIPN/A
Phone636-537-9715
Debt
Debt-to-Equity RatioN/A
Current Ratio1.25
Quick Ratio0.66
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$41.79 million
Price / Sales0.22
Cash Flow$0.3835 per share
Price / Cash12.70
Book Value$7.78 per share
Price / Book0.63
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$-690,000.00
Net Margins-3.74%
Return on Equity-6.56%
Return on Assets-4.40%
Miscellaneous
Employees160
Outstanding Shares1,850,000
Reliv International (NASDAQ:RELV) Frequently Asked Questions
What is Reliv International's stock symbol?
Reliv International trades on the NASDAQ under the ticker symbol "RELV."
How were Reliv International's earnings last quarter?
Reliv International, Inc (NASDAQ:RELV) announced its quarterly earnings data on Friday, May, 11th. The company reported ($0.13) EPS for the quarter. The firm earned $10 million during the quarter. Reliv International had a negative net margin of 3.74% and a negative return on equity of 6.56%. View Reliv International's Earnings History.
Who are some of Reliv International's key competitors?
Some companies that are related to Reliv International include AEterna Zentaris (AEZS), Ceapro (CRPOF), OvaScience (OVAS), Vistagen Therapeutics (VTGN), ProPhase Labs (PRPH), KITOV PHARMA LT/S (KTOV), Catabasis Pharmaceuticals (CATB), Pernix Therapeutics (PTX), X T L Biopharmaceuticals (XTLB), Aralez Pharmaceuticals (ARLZ), Sernova (SEOVF), NeuroVive Pharmaceutical (NEVPF), Lipocine (LPCN), Citius Pharmaceuticals (CTXR) and Provectus Biopharmaceuticals (PVCT).
Who are Reliv International's key executives?
Reliv International's management team includes the folowing people:
- Mr. Robert L. Montgomery, Co-Founder, Chairman and Chief Exec. Officer (Age 76)
- Dr. Carl W. Hastings Ph.D., Vice Chairman, Chief Scientific Officer and Member of the Scientific Advisory Board (Age 76)
- Mr. Stephen M. Merrick, Sr. VP, Gen. Counsel and Sec. (Age 76)
- Mr. Ryan A. Montgomery, Pres (Age 44)
- Mr. Steven D. Albright CPA, Chief Financial Officer and Sr. VP (Age 56)
Has Reliv International been receiving favorable news coverage?
News headlines about RELV stock have trended positive this week, according to Accern Sentiment Analysis. The research group identifies positive and negative media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Reliv International earned a news sentiment score of 0.25 on Accern's scale. They also assigned news headlines about the company an impact score of 47.24 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near future.
How do I buy shares of Reliv International?
Shares of RELV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Reliv International's stock price today?
One share of RELV stock can currently be purchased for approximately $4.87.
How big of a company is Reliv International?
Reliv International has a market capitalization of $9.04 million and generates $41.79 million in revenue each year. Reliv International employs 160 workers across the globe.
How can I contact Reliv International?
Reliv International's mailing address is 136 CHESTERFIELD INDUSTRIAL BLVD, CHESTERFIELD MO, 63005. The company can be reached via phone at 636-537-9715 or via email at [email protected]
MarketBeat Community Rating for Reliv International (RELV)
MarketBeat's community ratings are surveys of what our community members think about Reliv International and other stocks. Vote "Outperform" if you believe RELV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RELV will underperform the S&P 500 over the long term. You may vote once every thirty days.
